Menard Financial Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-303
Closed -$79K 108
2024
Q4
$79K Buy
+303
New +$89.9K 0.05% 166
2021
Q3
Sell
-2,414
Closed -$588K 158
2021
Q2
$588K Sell
2,414
-145
-6% -$35.7K 0.56% 47
2021
Q1
$637K Sell
2,559
-251
-9% -$59.9K 0.68% 36
2020
Q4
$646K Sell
2,810
-449
-14% -$104K 0.7% 38
2020
Q3
$828K Buy
3,259
+406
+14% +$101K 0.96% 22
2020
Q2
$673K Buy
+2,853
New +$651K 0.84% 23
2020
Q1
Sell
-2,016
Closed -$486K 30
2019
Q4
$486K Buy
+2,016
New +$444K 0.47% 77

Other funds holding AMGN

Menard Financial Group's AMGN Position: Q1 2025 in Review

Menard Financial Group sold out of Amgen (AMGN) in Q1 2025, closing a stake of 303 shares — an estimated $79K sold.

Menard Financial Group first reported a position in AMGN in Q4 2019 and held it in 7 quarters. The position peaked at $828K in Q3 2020. 2,926 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.

  • Menard Financial Group reported no remaining Amgen position as of Q1 2025 after selling out during the quarter.
  • Menard Financial Group sold 303 Amgen shares in Q1 2025, an estimated $79K.
  • Menard Financial Group first reported a position in Amgen in Q4 2019 and held it in 7 quarters.
  • Menard Financial Group's Amgen position peaked at $828K in Q3 2020.
  • 2,926 funds tracked by Wall St. Rank held Amgen as of Q1 2025.

Based on Menard Financial Group's 13F filing for Q1 2025, filed 8 May 2025.